Reducing Inhaler Testing Variability Through Test Environment Control In this Q&A with OINDPnews, our CEO Mark Copley answers questions about the importance of the test environment for OIP testing.
The Combined Effect of Valve and Spray Orifice Diameters on pMDI Plume Force Ben Myatt, Barzin Gavtash, Lee Hodges & Andy Cooper Kindeva Drug Delivery, Loughborough, Leicestershire, UK Spray...
In Vitro Regional Deposition of Nasal Sprays in an Idealized Nasal Inlet: Comparison with In Vivo Gamma Scintigraphy John Z. Chen, Warren H. Finlay and Andrew R. Martin Department of...
Dissolution Testing: An established technique driving advances in drug delivery This article introduces dissolution testing and highlights its ability to support modern formulation challenges. Pharmacopoeial methods are discussed with reference...
Improving In Vitro Test Methods for Nasal Drug Products In this article, we look at how in vitro testing is being refined for greater repeatability and to maximise its value as...
Refining Test Methods for a New Generation of Nasal Drug Products The nasal drug product market is currently the focus of considerable research activity. Here, Mark Copley (CEO) and Anna...
Semi-Automating Inhaler Testing - A Good Idea, but Where to Start? Cascade impaction is a vital technique in the development and manufacture of orally inhaled and nasal drug products (OINDPs),...
Putting Inhalers to the Test Anna Sipitanou has worked for Copley Scientific for four years, expanding her drug discovery and pharma science background. She sat down with PMPS to discuss...
A short Q&A with our CEO, Mark Copley, on inhaled product testing
Semi-Automation in Inhaler Testing – Exploring the Potential and Practicalities In this article, João Pereira, Team Leader R&D Analytical Development, and Raquel Borda D’Água, Associated Analytical Chemist, both at Hovione,...